Literature DB >> 34010395

Short-coupled ventricular fibrillation represents a distinct phenotype among latent causes of unexplained cardiac arrest: a report from the CASPER registry.

Christian Steinberg1, Brianna Davies2, Greg Mellor3, Rafik Tadros4, Zachary W Laksman2, Jason D Roberts5, Martin Green6, Wael Alqarawi6, Paul Angaran7, Jeffrey Healey8, Shubhayan Sanatani9, Richard Leather10, Colette Seifer11, Anne Fournier12, Henry Duff13, Martin Gardner14, Ciorsti McIntyre14, Robert Hamilton15, Christopher S Simpson16, Andrew D Krahn2.   

Abstract

AIMS : The term idiopathic ventricular fibrillation (IVF) describes survivors of unexplained cardiac arrest (UCA) without a specific diagnosis after clinical and genetic testing. Previous reports have described a subset of IVF individuals with ventricular arrhythmia initiated by short-coupled trigger premature ventricular contractions (PVCs) for which the term short-coupled ventricular fibrillation (SCVF) has been proposed. The aim of this article is to establish the phenotype and frequency of SCVF in a large cohort of UCA survivors. METHODS AND RESULTS : We performed a multicentre study including consecutive UCA survivors from the CASPER registry. Short-coupled ventricular fibrillation was defined as otherwise unexplained ventricular fibrillation initiated by a trigger PVC with a coupling interval of <350 ms. Among 364 UCA survivors, 24/364 (6.6%) met diagnostic criteria for SCVF. The diagnosis of SCVF was obtained in 19/24 (79%) individuals by documented ventricular fibrillation during follow-up. Ventricular arrhythmia was initiated by a mean PVC coupling interval of 274 ± 32 ms. Electrical storm occurred in 21% of SCVF probands but not in any UCA proband (P < 0.001). The median time to recurrent ventricular arrhythmia in SCVF was 31 months. Recurrent ventricular fibrillation resulted in quinidine administration in 12/24 SCVF (50%) with excellent arrhythmia control. CONCLUSION : Short-coupled ventricular fibrillation is a distinct primary arrhythmia syndrome accounting for at least 6.6% of UCA. As documentation of ventricular fibrillation onset is necessary for the diagnosis, most cases are diagnosed at the time of recurrent arrhythmia, thus the true prevalence of SCVF remains still unknown. Quinidine is effective in SCVF and should be considered as first-line treatment for patients with recurrent episodes. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2021. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  CASPER; Idiopathic ventricular fibrillation; Premature ventricular contraction; Quinidine; Short-coupled ventricular fibrillation; Unexplained cardiac arrest

Year:  2021        PMID: 34010395     DOI: 10.1093/eurheartj/ehab275

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  6 in total

1.  Multifocal Purkinje-related premature contractions and electrical storm suppressed by quinidine and verapamil in a case with short-coupled ventricular fibrillation.

Authors:  Naoya Kataoka; Satoshi Nagase; Keisuke Okawa; Takeshi Aiba; Koichiro Kinugawa; Kengo Kusano
Journal:  J Cardiol Cases       Date:  2021-12-30

2.  Idiopathic ventricular fibrillation triggered by premature ventricular complexes originating from the false tendon of the left ventricle.

Authors:  Zeba Hashmath; Aditi Naniwadekar
Journal:  HeartRhythm Case Rep       Date:  2022-05-13

3.  Red herring pathogenic variants: a case report of premature ventricular contraction-triggered ventricular fibrillation with an incidental pathogenic LMNA variant.

Authors:  Ramin Garmany; Raquel Neves; Fatima Ali Ahmed; David J Tester; Bryan C Cannon; John R Giudicessi; Michael J Ackerman
Journal:  Eur Heart J Case Rep       Date:  2022-03-17

Review 4.  Developing a Mechanistic Approach to Sudden Death Prevention in Mitral Valve Prolapse.

Authors:  Brian P Kelley; Abdul Mateen Chaudry; Faisal F Syed
Journal:  J Clin Med       Date:  2022-02-26       Impact factor: 4.241

5.  High-resolution mapping and successful ablation of Purkinje ectopy-triggered ventricular fibrillation storm.

Authors:  Alexandre Raymond-Paquin; Scott Lovejoy; Kenneth A Ellenbogen; Santosh K Padala
Journal:  HeartRhythm Case Rep       Date:  2021-12-29

6.  The year in cardiovascular medicine 2021: arrhythmias.

Authors:  Harry J G M Crijns; Prashantan Sanders; Christine M Albert; Pier D Lambiase
Journal:  Eur Heart J       Date:  2022-03-21       Impact factor: 35.855

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.